You are here

  • Home
  • Archive
  • Volume 78, Issue 5
  • Achieving remission in psoriatic arthritis by early initiation of TNF inhibition: a double-blind, randomised, placebo-controlled trial of golimumab plus methotrexate versus placebo plus methotrexate

Article info

Article menu

Download PDFPDF

Psoriatic arthritis
Achieving remission in psoriatic arthritis by early initiation of TNF inhibition: a double-blind, randomised, placebo-controlled trial of golimumab plus methotrexate versus placebo plus methotrexate

Authors

  • Leonieke J J van Mens Clinical Immunology and Rheumatology, Amsterdam UMC, AMC/University of Amsterdam, Amsterdam, The Netherlands Amsterdam Rheumatology and immunology Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Henriëtte M de Jong Clinical Immunology and Rheumatology, Amsterdam UMC, AMC/University of Amsterdam, Amsterdam, The Netherlands Amsterdam Rheumatology and immunology Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Inka Fluri Clinical Immunology and Rheumatology, Amsterdam UMC, AMC/University of Amsterdam, Amsterdam, The Netherlands Amsterdam Rheumatology and immunology Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Michael T Nurmohamed Amsterdam Rheumatology and immunology Center, Amsterdam, The Netherlands Clinical Immunology and Rheumatology, Amsterdam UMC, VU University, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Marleen G H van de Sande Clinical Immunology and Rheumatology, Amsterdam UMC, AMC/University of Amsterdam, Amsterdam, The Netherlands Amsterdam Rheumatology and immunology Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Marc Kok Rheumatology, Maasstad Ziekenhuis, Rotterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Arno W R van Kuijk Amsterdam Rheumatology and immunology Center, Amsterdam, The Netherlands Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Dominique Baeten Clinical Immunology and Rheumatology, Amsterdam UMC, AMC/University of Amsterdam, Amsterdam, The Netherlands Amsterdam Rheumatology and immunology Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Dominique Baeten, Clinical Immunology and Rheumatology, Amsterdam UMC, AMC/University of Amsterdam, Amsterdam 1011 AA, The Netherlands; d.l.baeten{at}amc.uva.nl
View Full Text

Citation

van Mens LJJ, de Jong HM, Fluri I, et al
Achieving remission in psoriatic arthritis by early initiation of TNF inhibition: a double-blind, randomised, placebo-controlled trial of golimumab plus methotrexate versus placebo plus methotrexate
Annals of the Rheumatic Diseases 2019;78:610-616.

Publication history

  • Received November 11, 2018
  • Revised January 26, 2019
  • Accepted February 4, 2019
  • First published February 26, 2019.
Online issue publication 
April 07, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: http://creativecommons.org/licenses/by/4.0/.